1
|
Dessy E, Falleni M, Braidotti P, Del Curto
B, Panigalli T and Pietra GG: Unusual clear cell variant of
epithelioid mesothelioma. Arch Pathol Lab Med. 125:1588–1590.
2001.PubMed/NCBI
|
2
|
Robinson BW and Lake RA: Advances in
malignant mesothelioma. N Engl J Med. 353:1591–1603. 2005.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Munkholm-Larsen S, Cao CQ and Yan TD:
Malignant peritoneal mesothelioma. World J Gastrointest Surg.
1:38–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
D'Ambrosio V: Mesothelioma as primary
tumor of the peritoneum. A case report. J Med Soc N J. 70:637–639.
1973.PubMed/NCBI
|
5
|
Hammar SP: Macroscopic, histologic,
histochemical, immunohistochemical, and ultrastructural features of
mesothelioma. Ultrastruct Pathol. 30:3–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Gkogkou C, Samitas K and Foteinou M:
Primary pleural epithelioid mesothelioma of clear cell type: A case
report and review of current literature. Ultrastruct Pathol.
35:267–270. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ordóñez NG: Mesothelioma with clear cell
features: An ultrastructural and immunohistochemical study of 20
cases. Hum Pathol. 36:465–473. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Ordóñez NG: Clear cell mesothelioma
presenting as an incarcerated abdominal hernia. Virchows Arch.
447:823–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
de Pangher Manzini V: Malignant peritoneal
mesothelioma. Tumori. 91:1–5. 2005.PubMed/NCBI
|
10
|
Sugarbaker PH, Welch LS, Mohamed F and
Glehen O: A review of peritoneal mesothelioma at the washington
cancer institute. Surg Oncol Clin N Am. 12:605–621. 2003.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Riddell RH, Goodman MJ and Moossa AR:
Peritoneal malignant mesothelioma in a patient with recurrent
peritonitis. Cancer. 48:134–139. 1981. View Article : Google Scholar : PubMed/NCBI
|
12
|
Antman KH, Corson JM, Li FP, Greenberger
J, Sytkowski A, Henson DE and Weinstein L: Malignant mesothelioma
following radiation exposure. J Clin Oncol. 1:695–700.
1983.PubMed/NCBI
|
13
|
Chahinian AP, Pajak TF, Holland JF, Norton
L, Ambinder RM and Mandel EM: Diffuse malignant mesothelioma.
Prospective evaluation of 69 patients. Ann Intern Med. 96:746–755.
1982. View Article : Google Scholar : PubMed/NCBI
|
14
|
Maurer R and Egloff B: Malignant
peritoneal mesothelioma after cholangiography with thorotrast.
Cancer. 36:1381–1385. 1975. View Article : Google Scholar : PubMed/NCBI
|
15
|
De Pangher Manzini V, Brollo A and Bianchi
C: Thrombocytosis in malignant pleural mesothelioma. Tumori.
76:576–578. 1990.PubMed/NCBI
|
16
|
Piccigallo E, Jeffers LJ, Reddy KR,
Caldironi MW, Parenti A and Schiff ER: Malignant peritoneal
mesothelioma. A clinical and laparoscopic study of ten cases. Dig
Dis Sci. 33:633–639. 1988. View Article : Google Scholar : PubMed/NCBI
|
17
|
Mirabella F: Peritoneal mesothelioma and
abdominal hernias. Minerva Med. 87:21–24. 1996.(In Italian).
PubMed/NCBI
|
18
|
Smith TR: Malignant peritoneal
mesothelioma: Marked variability of CT findings. Abdom Imaging.
19:27–29. 1994. View Article : Google Scholar : PubMed/NCBI
|
19
|
Higashihara M, Sunaga S, Tange T, Oohashi
H and Kurokawa K: Increased secretion of interleukin-6 in malignant
mesothelioma cells from a patient with marked thrombocytosis.
Cancer. 70:2105–2108. 1992. View Article : Google Scholar : PubMed/NCBI
|
20
|
Melero M, Lloveras J, Waisman H, Elsner B
and Baldessari E: Malignant peritoneal mesothelioma. An infrequent
cause of prolonged fever syndrome and leucocytosis in a young
adult. Medicina (B Aires). 55:48–50. 1995.(In Spanish). PubMed/NCBI
|
21
|
Govender SS, Seebaran AR, Moodley V and
Rajput MC: Peritoneal mesothelioma complicated by colojejunal
fistula. A case report. S Afr J Surg. 25:103–105. 1987.PubMed/NCBI
|
22
|
McCaffrey JC, Foo FJ, Dalal N and Siddiqui
KH: Benign multicystic peritoneal mesothelioma associated with
hydronephrosis and colovesical fistula formation: Report of a case.
Tumori. 95:808–810. 2009.PubMed/NCBI
|
23
|
Yu GH, Soma L, Hahn S and Friedberg JS:
Changing clinical course of patients with malignant mesothelioma:
Implications for FNA cytology and utility of immunocytochemical
staining. Diagn Cytopathol. 24:322–327. 2001. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ahmed I, Ahmed Tipu S and Ishtiaq S:
Malignant mesothelioma. Pak J Med Sci. 29:1433–1438. 2013.(Review).
PubMed/NCBI
|
25
|
Baker PM, Clement PB and Young RH:
Malignant peritoneal mesothelioma in women: A study of 75 cases
with emphasis on their morphologic spectrum and differential
diagnosis. Am J Clin Pathol. 123:724–737. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Chhieng DC, Yee H, Schaefer D, Cangiarella
JF, Jagirdar J, Chiriboga LA, Jagirdar J, Chiriboga LA and Cohen
JM: Calretinin staining pattern aids in the differentiation of
mesothelioma from adenocarcinoma in serous effusions. Cancer.
90:194–200. 2000. View Article : Google Scholar : PubMed/NCBI
|
27
|
Saad RS, Cho P, Liu YL and Silverman JF:
The value of epithelial membrane antigen expression in separating
benign mesothelial proliferation from malignant mesothelioma: A
comparative study. Diagn Cytopathol. 32:156–159. 2005. View Article : Google Scholar : PubMed/NCBI
|
28
|
Eltabbakh GH, Piver MS, Hempling RE, Recio
FO and Intengen ME: Clinical picture, response to therapy, and
survival of women with diffuse malignant peritoneal mesothelioma. J
Surg Oncol. 70:6–12. 1999. View Article : Google Scholar : PubMed/NCBI
|
29
|
Sugarbaker PH, Yan TD, Stuart OA and Yoo
D: Comprehensive management of diffuse malignant peritoneal
mesothelioma. Eur J Surg Oncol. 32:686–691. 2006. View Article : Google Scholar : PubMed/NCBI
|
30
|
Feldman AL, Libutti SK, Pingpank JF,
Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ,
Kleiner DE and Alexander HR: Analysis of factors associated with
outcome in patients with malignant peritoneal mesothelioma
undergoing surgical debulking and intraperitoneal chemotherapy. J
Clin Oncol. 21:4560–4567. 2003. View Article : Google Scholar : PubMed/NCBI
|